CNS vs TROW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CNS

59.9
AI Score
VS
TROW Wins

TROW

60.1
AI Score

Investment Advisor Scores

CNS

Oct 02, 2026
60score
Recommendation
HOLD

TROW

Oct 02, 2026
60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS TROW Winner
Forward P/E 18.4502 10.1523 TROW
PEG Ratio 1.6881 2.1611 CNS
Revenue Growth 12.2% 10.7% CNS
Earnings Growth 31.9% 28.6% CNS
Tradestie Score 59.9/100 60.1/100 TROW
Profit Margin 28.8% 29.3% TROW
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% TROW 1M: -2.5% · 3M: -10.5%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

TROW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $106.66

Fundamentals Snapshot

Metric CNS TROW
Market Cap — —
Forward P/E 18.4 10.3
Trailing P/E 22.4 10.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.3% 0.3%
EPS 3.26 9.92
Dividend Yield 0.04% 0.05%

Frequently Asked Questions

Based on our detailed analysis, TROW is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.